Advisor Partners LLC Purchases 188 Shares of AmerisourceBergen Corp. (NYSE:ABC)

Share on StockTwits

Advisor Partners LLC lifted its position in AmerisourceBergen Corp. (NYSE:ABC) by 4.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,118 shares of the company’s stock after buying an additional 188 shares during the quarter. Advisor Partners LLC’s holdings in AmerisourceBergen were worth $339,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently made changes to their positions in ABC. Vanguard Group Inc. grew its stake in shares of AmerisourceBergen by 16.8% in the 2nd quarter. Vanguard Group Inc. now owns 18,910,594 shares of the company’s stock valued at $1,612,318,000 after buying an additional 2,719,868 shares in the last quarter. Amundi Pioneer Asset Management Inc. grew its stake in shares of AmerisourceBergen by 493.2% in the 2nd quarter. Amundi Pioneer Asset Management Inc. now owns 757,887 shares of the company’s stock valued at $64,617,000 after buying an additional 630,123 shares in the last quarter. Skandinaviska Enskilda Banken AB publ boosted its position in AmerisourceBergen by 1,584.3% during the second quarter. Skandinaviska Enskilda Banken AB publ now owns 490,101 shares of the company’s stock worth $41,786,000 after purchasing an additional 461,002 shares during the period. Nuveen Asset Management LLC boosted its position in AmerisourceBergen by 111.5% during the second quarter. Nuveen Asset Management LLC now owns 738,360 shares of the company’s stock worth $62,953,000 after purchasing an additional 389,252 shares during the period. Finally, Victory Capital Management Inc. boosted its position in AmerisourceBergen by 9.7% during the second quarter. Victory Capital Management Inc. now owns 2,769,023 shares of the company’s stock worth $236,087,000 after purchasing an additional 245,394 shares during the period. 65.99% of the stock is owned by institutional investors and hedge funds.

In other news, EVP John G. Chou sold 13,997 shares of the company’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $81.48, for a total transaction of $1,140,475.56. Following the completion of the transaction, the executive vice president now directly owns 65,782 shares in the company, valued at $5,359,917.36. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Steven H. Collis sold 19,905 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $89.58, for a total value of $1,783,089.90. Following the transaction, the chief executive officer now owns 154,484 shares of the company’s stock, valued at $13,838,676.72. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 109,506 shares of company stock valued at $9,412,050. Corporate insiders own 27.80% of the company’s stock.

ABC has been the subject of a number of recent analyst reports. Morgan Stanley decreased their target price on AmerisourceBergen from $91.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, September 6th. ValuEngine raised AmerisourceBergen from a “sell” rating to a “hold” rating in a research report on Thursday. Deutsche Bank initiated coverage on AmerisourceBergen in a research report on Thursday, September 12th. They set a “hold” rating and a $91.00 target price for the company. Finally, TheStreet raised AmerisourceBergen from a “c+” rating to a “b” rating in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company. AmerisourceBergen has an average rating of “Hold” and an average target price of $87.38.

Shares of AmerisourceBergen stock opened at $89.64 on Monday. The stock has a market capitalization of $18.81 billion, a P/E ratio of 13.81, a PEG ratio of 1.49 and a beta of 1.00. The company has a quick ratio of 0.56, a current ratio of 0.95 and a debt-to-equity ratio of 1.40. The stock has a 50 day moving average price of $83.51 and a two-hundred day moving average price of $82.56. AmerisourceBergen Corp. has a 12-month low of $69.36 and a 12-month high of $94.85.

AmerisourceBergen (NYSE:ABC) last announced its earnings results on Thursday, August 1st. The company reported $1.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.14. AmerisourceBergen had a return on equity of 47.88% and a net margin of 0.54%. The firm had revenue of $45.24 billion during the quarter, compared to analysts’ expectations of $45.15 billion. During the same quarter in the prior year, the business earned $1.54 earnings per share. The company’s revenue was up 4.9% on a year-over-year basis. Sell-side analysts anticipate that AmerisourceBergen Corp. will post 7.05 earnings per share for the current year.

AmerisourceBergen Profile

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Featured Article: What are the qualifications of a portfolio manager?

Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.